Indonesia Syringe Market Size, Share, Opportunities, And Trends By Type (Insulin Syringe, Conventional Syringe), By Material (Glass, Plastic, Stainless Steel), And By Syringe Size (Smaller Volume Syringe, Larger Volume Syringe) - Forecasts From 2023 To 2028

  • Published : Feb 2023
  • Report Code : KSI061614446
  • Pages : 90

Indonesia is benefiting from greater purchasing power and improved exposure to healthcare facilities as the country's economic situation improves. The government has substantially enhanced expenditures on health care and programs supported by medicine for Indonesia's poor households. The lifestyle and dietary habits of Indonesians are changing as a result of the country's improving economic situation. This aggravates lifestyle-related health conditions like high blood pressure and hypertension. As a result, the demand for medicines and the medical equipment needed to administer them, such as syringes, has surged in Indonesia in recent years, supporting the country's syringe industry.

The Indonesia syringe market is driven by the rising patient population affected by several diseases in the country.

In Indonesia, there are many cases of unusual diseases and fatal ailments. According to data from the world health organization (WHO), there were around 11.66 million active cases affected by kidney diseases while there were more than 10 million active diabetes patients in Indonesia in 2021. The data also stated that there were 260K patients suffering from cardiac ailments and around 400K people were suffering from different types of cancers and tuberculosis respectively in 2021. As such, the rising prevalence of several diseases and the increasing number of patients suffering from such ailments has resulted in increased demand for medical equipment for treatment, including syringes, defibrillators, and surgical tables. As such, the growing patient population in the country has favorably impacted the Indonesian syringe market.

As a substitute for the medical and healthcare services provided in hospitals, Indonesians believe in and employ a variety of traditional medical treatments and medications. Despite the fact that a large number of people are eligible for the program, access to modern healthcare is still limited for a variety of reasons, such as a lack of hospitals and clinics, a lack of knowledge, and lengthy and complicated bureaucracies for those who receive government-sponsored healthcare services. As a result, this hinders the expansion of the Indonesian syringe market.

Key Developments.

  • In November 2022, The Asian Development Bank (ADB) bought approximately 1 billion shares for US$12.2 million on the Indonesian Stock Exchange in November 2022 as part of the initial public offering (IPO) of Jayamas Medica Industri (OneMed), the largest producer and distributor of medical supplies, including syringes in Indonesia. With the help of the IPO revenues, OneMed will able to double the number of manufacturing facilities from two to four, increase the number of national distribution centres from one to two, add 15 warehouses, and open 25 additional retail locations. The survival and growth of Indonesia's national health insurance program, Jaminan Kesehatan Nasional, depend on the availability of reasonably priced medical equipment and supplies, which has been aided by this investment.

The extensive healthcare industry and the rising number of hospitals in the country are expected to help the Indonesian syringe market.

The number of hospitals in the country has grown and is anticipated to grow even more throughout the projected period as a result of the need to expand the capacity of healthcare facilities, as well as the significant growth in healthcare spending and optimistic economic outlook following the COVID-19 pandemic. The Indonesian government announced investments as part of the law for medical device suppliers, hospitals, pharmaceutical wholesalers, and pharmaceutical manufacturers. The Indonesian syringe market has benefitted tremendously as a result.

Indonesia Syringe Market Scope:

 

Report Metric Details
 Growth Rate  CAGR during the forecast period
 Base Year  2021
 Forecast Period  2023 – 2028
 Forecast Unit (Value)  USD Billion
 Segments Covered  Type, Material, And Syringe Size
 Companies Covered PT. Nipro Indonesia Jaya, B Braun SE, PT Oneject Indonesia (TDC Indonesia), PT. Becton Dickinson Indonesia, ICU Medical, Inc., PT TOP POINT MEDICA
 Customization Scope  Free report customization with purchase

 

Key Market Segments

  • By Type
    • Insulin Syringe
    • Conventional Syringe
      • Eccentric Tip Syringe
      • Catheter Tip Syringe
      • Luer Lock Syringe
  • By Material
    • Glass
    • Plastic
    • Stainless Steel
  • By Syringe Size
    • Smaller Volume Syringe
    • Larger Volume Syringe

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data

2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. INDONESIA SYRINGE MARKET, BY TYPE 

5.1. Introduction

5.2. Insulin Syringe

5.3. Conventional Syringe

5.3.1. Eccentric Tip Syringe

5.3.2. Catheter Tip Syringe

5.3.3. Luer Lock Syringe

6. INDONESIA SYRINGE MARKET, BY MATERIAL

6.1. Introduction

6.2. Glass

6.3. Plastic

6.4. Stainless Steel

7. INDONESIA SYRINGE MARKET, BY SYRINGE SIZE

7.1. Introduction

7.2. Smaller Volume Syringe

7.3. Larger Volume Syringe

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Emerging Players and Market Lucrativeness

8.3. Mergers, Acquisition, Agreements, and Collaborations

8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. PT. Nipro Indonesia Jaya

9.2. B Braun SE

9.3. PT Oneject Indonesia (TDC Indonesia)

9.4.  PT. Becton Dickinson Indonesia

9.5. ICU Medical, Inc.

9.6. PT TOP POINT MEDICA


PT. Nipro Indonesia Jaya

B Braun SE

PT Oneject Indonesia (TDC Indonesia)

PT. Becton Dickinson Indonesia

ICU Medical, Inc.

PT TOP POINT MEDICA